Chloramphenicol in children: Dose, plasma levels and clinical effects

Annals of Tropical Paediatrics

Volumn 18, Issue 2, 1998, Pages 123-128

  Ismail, R ^a   Teh, L K ^a   Choo, E K ^b  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

^b General Hospital Kota Bharu   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL;

ARTICLE; BLOOD DISEASE; BODY TEMPERATURE; CHILD; CLINICAL TRIAL; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MONITORING; FEVER; HEMATOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MENINGITIS; MULTICENTER STUDY; NEWBORN; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME; TYPHOID FEVER;

EID: 0031747291     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1080/02724936.1998.11747938     Document Type: Article

References (21)

1. Sutherland JM. Fatal cardiovascular collapse of infants receiving a large amount of chloramphenicol. Am J Dis Child 1959; 97:761-7.
2. Rich ML, Ritterhoff RJ, Hoffman RJ. A fatal case of aplastic anaemia following chloramphenicol therapy. Ann Int Med 1950; 33:1459-67.
3. Yunis AA. Chloramphenicol induced bone marrow suppression. Semin Haematol 1973; 10:225-34.
4. Taylor WJ, Caviness MHD, eds. Antibiotics and other anti-infective agents. In: A Textbook of The Clinical Application of Therapeutic Drug Monitoring. Irving, Texas: Abbott, 1986; 329-38.
5. Cristiano P, Imparato L, Carpinelli C, et al. Pefloxacin vs chloramphenicol in the therapy of typhoid fever. Infection 1995; 23,2:103-6.
6. Koup JR, Lau AH, Brodsky B, Slaughter RL. Chloramphenicol pharmacokinetics in hospitalized patients. Antimicrob Agents Chemother 1979; 5:651-5.
7. Coakley JC, Hudson I, Shann F, Connelly JF. A review of therapeutic monitoring of chloramphenicol in patients with Haemophilus influenzae meningitis. J Pediatr Child Health 1992; 3:249-53.
8. Nahata MC. Serum concentrations and adverse effects of chloramphenicol in pediatric patients. Chemotherapy 1987; 33:322-7.
9. Rajchgot P, Prober CG, Soldin S, et al. Initiation of chloramphenicol therapy in the newborn infant. J Pediatr 1982; 60:1018-21.
10. Mirza SH, Beeching NJ, Hart CA. Multi-drug resistant typhoid: A global problem. J Med Microbiol 1996; 5:317-19.
11. Islam A, Butler T, Kabir I, Alam NH. Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: A randomized clinical trial. Antimicrob Agents Chemother 1993; 8:1572-5.
12. Ekblad H, Ruuskanen O, Lindberg R, Iisalo E, The monitoring of chloramphenicol in children with severe infections. J Antimicrob Agents Chemother 1985; 15:489-94.
13. Dameshek W. Chloramphenicol aplastic anaemia in identical twins - a clue to pathogenesis. N Engl J Med 1969; 281:42-3.
14. Girgis NI, Sultan Y, Hammad O, Farid Z. Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children. Pediatr Infect Dis J 1995; 7:603-5.
15. Ashwal S, Perkin RM, Thompson JR, et al. Bacterial meningitis in children: current concepts of neurologic management. Adv Pediatr 1993; 40:185-215.
16. Peltola H, Anttila M, Renkonen OV. Randomized comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Lancet 1989; 1:1281-7.
17. Ambrose PJ. Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate. Clin Pharmacokinet 1984; 3:222-38.
18. Ti TY, Monteiro EH, Lam S, Lee HS. Chloramphenicol concentrations in sera of patients with typhoid fever being treated with oral or intravenous preparations. Antimicrob Agents Chemother 1990;9:1809-11.
19. Kauffman RE, Miceli JN, Strebel L, et al. Pharmacokinetics of chloramphenicol and chloramphenicol succinate in infants and children. J Pediatr 1981; 98:315-20.
20. Kauffman RE, Thirumoorthi MC, Buckley JA, et al. Pediatric pharmacology and therapeutics. Relative bioavailability of intravenous chloramphenicol succinate and oral chloramphenicol palmitate in infants and children. J Pediatr 1981; 6:963-7.
21. Oski FA. Hematological consequences of chloramphenicol therapy. J Pediatr 1979; 94:515-16.